One explanation for this is likely the combination of CD20 with a low CD59 expression, as blocking CD59 on CD20+ B-cell lymphoma cells with a high CD59 expression, rendered them sensitive to RTX-mediated CDC when cultured in 2D. This evidence concerns the gene CD59 and B-cell non-Hodgkin lymphoma.